Skip to main content
. Author manuscript; available in PMC: 2016 Jul 7.
Published in final edited form as: Nutr Cancer. 2016 Jan 15;68(1):154–164. doi: 10.1080/01635581.2016.1115104

Figure 4.

Figure 4

Effect of genistein on cell viability and apoptosis in breast cancer cells expressing control or miR-155 vector. MDA-MB-435 or Hs578t cells stably expressing control or miR-155 vector were treated with vehicle or genistein for 48 h. Left, MDA-MB-435; right, Hs578t. A: Cell viability as a percentage of vehicle (100%). B: Apoptosis. Fold changes in caspase 3/7 activity from vehicle are shown (N = 3 ± SEM, *P < 0.05). Genistein treatments compared to vehicle. #P < 0.05, cells ectopically expressing miR-155 compared with cells expressing control vector.